Vanta Bioscience Reports FY26 Results and Re-appoints Managing Director
Vanta Bioscience Ltd 路 Financial Result 路 31 May 2026, 2:05 am
Vanta Bioscience Reports FY26 Results and Re-appoints Managing Director Vanta Bioscience approved its audited FY26 results on 30 May'26. On a consolidated basis, FY26 revenue was Rs. 197.59 Lacs, with a net profit after tax of Rs. 10.83 Lacs, a significant turnaround from the Rs. 267.09 Lacs loss in FY25. For H2 FY26, the company posted a net profit of Rs. 192.72 Lacs. The Board also approved the re-appointment of Mr. Dopesh Raja Mulakala as Managing Director for three years, effective 18 Apr'26. The statutory auditor provided an unqualified opinion on the financial statements.
Original exchange filing (PDF)
More announcements from Vanta Bioscience Ltd
- Outcome of Board Meeting 路 14 Nov 2026
- Outcome of Board Meeting 路 14 Nov 2026
- Vanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Intimation of Board Meeting .... 路 13 Nov 2026
- Vanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Intimation of Board Meeting .... 路 13 Nov 2026
- Submission of AGM Proceedings, Voting Results and Scrutinizers Report for the 10th Annual General Meeting 路 01 Oct 2026
- Submission of AGM Proceedings, Voting Results and Scrutinizer''s Report for the 10th AGM 路 01 Oct 2026
- Outcome of Board Meeting held on 05.09.2026 - 10th AGM to be held on 30.09.2026 路 05 Sept 2026
- Outcome of the Board Meeting held on 30.05.2026 路 31 May 2026
